within Pharmacolibrary.Drugs.ATC.C;

model C10BX12
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.145,
    Cl             = 0.00095,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,   // mg â†’ kg
    adminCount     = 1,
    Vd             = 0.4,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.015000000000000001,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C10BX12</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>This fixed-dose combination drug contains atorvastatin (a statin for lowering cholesterol), acetylsalicylic acid (aspirin, an antiplatelet agent), and perindopril (an ACE inhibitor for hypertension and heart failure). It is used for cardiovascular prevention, secondary prevention post-myocardial infarction, and management of patients with mixed dyslipidemia and hypertension. The combination is approved and marketed in some jurisdictions under the ATC code C10BX12.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for combination product in average healthy adult individuals, as no primary source with detailed pharmacokinetics for the fixed combination was found. Parameters are synthesized from known component kinetics.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C10BX12;
